Year |
Citation |
Score |
2013 |
Coleman BR, Carlezon WA, Myers KM. Extinction of conditioned opiate withdrawal in rats is blocked by intracerebroventricular infusion of an NMDA receptor antagonist. Neuroscience Letters. 541: 39-42. PMID 23416323 DOI: 10.1016/j.neulet.2013.01.049 |
0.617 |
|
2013 |
Myers KM, Claycomb R, Tai TC, Carlezon WA, Kvetnansky R, Wong DL. Stress, HIF1a, and Adrenergic Function Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 221-222. DOI: 10.1016/B978-0-12-800044-1.00198-7 |
0.425 |
|
2012 |
Myers KM, Carlezon WA. D-cycloserine effects on extinction of conditioned responses to drug-related cues. Biological Psychiatry. 71: 947-55. PMID 22579305 DOI: 10.1016/j.biopsych.2012.02.030 |
0.592 |
|
2012 |
Myers KM, Bechtholt-Gompf AJ, Coleman BR, Carlezon WA. Extinction of conditioned opiate withdrawal in rats in a two-chambered place conditioning apparatus. Nature Protocols. 7: 517-26. PMID 22362157 DOI: 10.1038/nprot.2011.458 |
0.579 |
|
2012 |
Cho JH, Bayazitov IT, Meloni EG, Myers KM, Carlezon WA, Zakharenko SS, Bolshakov VY. Coactivation of thalamic and cortical pathways induces input timing-dependent plasticity in amygdala. Nature Neuroscience. 15: 113-22. PMID 22158512 DOI: 10.1038/Nn.2993 |
0.532 |
|
2012 |
Wong DL, Tai TC, Wong-Faull DC, Claycomb R, Meloni EG, Myers KM, Carlezon WA, Kvetnansky R. Epinephrine: a short- and long-term regulator of stress and development of illness : a potential new role for epinephrine in stress. Cellular and Molecular Neurobiology. 32: 737-48. PMID 22090159 DOI: 10.1007/s10571-011-9768-0 |
0.53 |
|
2012 |
Myers KM, Carlezon WA. Reply to: Maintaining clinical relevance: Considerations for the future of research into D-cycloserine and cue exposure therapy for addiction Biological Psychiatry. 72: e31-e32. DOI: 10.1016/j.biopsych.2012.06.004 |
0.512 |
|
2011 |
Smith KS, Meloni EG, Myers KM, Van't Veer A, Carlezon WA, Rudolph U. Reduction of fear-potentiated startle by benzodiazepines in C57BL/6J mice. Psychopharmacology. 213: 697-706. PMID 20922362 DOI: 10.1007/s00213-010-2026-1 |
0.667 |
|
2011 |
Myers KM, Carlezon WA, Davis M. Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 274-93. PMID 20631689 DOI: 10.1038/npp.2010.88 |
0.62 |
|
2010 |
Choi DC, Maguschak KA, Ye K, Jang SW, Myers KM, Ressler KJ. Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear. Proceedings of the National Academy of Sciences of the United States of America. 107: 2675-80. PMID 20133801 DOI: 10.1073/Pnas.0909359107 |
0.421 |
|
2010 |
Myers KM, Carlezon WA. Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction. Neuroscience and Biobehavioral Reviews. 35: 285-302. PMID 20109490 DOI: 10.1016/j.neubiorev.2010.01.011 |
0.576 |
|
2010 |
Myers KM, Carlezon WA. D-cycloserine facilitates extinction of naloxone-induced conditioned place aversion in morphine-dependent rats. Biological Psychiatry. 67: 85-7. PMID 19782965 DOI: 10.1016/j.biopsych.2009.08.015 |
0.613 |
|
2010 |
Davis M, Myers KM. Pharmacology of fear extinction Encyclopedia of Neuroscience. 595-600. DOI: 10.1016/B978-008045046-9.00758-0 |
0.366 |
|
2009 |
Jovanovic T, Norrholm SD, Fennell JE, Keyes M, Fiallos AM, Myers KM, Davis M, Duncan EJ. Posttraumatic stress disorder may be associated with impaired fear inhibition: relation to symptom severity. Psychiatry Research. 167: 151-60. PMID 19345420 DOI: 10.1016/J.Psychres.2007.12.014 |
0.414 |
|
2008 |
Norrholm SD, Vervliet B, Jovanovic T, Boshoven W, Myers KM, Davis M, Rothbaum B, Duncan EJ. Timing of extinction relative to acquisition: a parametric analysis of fear extinction in humans. Behavioral Neuroscience. 122: 1016-30. PMID 18823159 DOI: 10.1037/A0012604 |
0.474 |
|
2008 |
Myers KM, Davis M. Chapter 2.3 Extinction of fear: From animal studies to clinical interventions Handbook of Behavioral Neuroscience. 17: 49-62. DOI: 10.1016/S1569-7339(07)00004-5 |
0.487 |
|
2007 |
Myers KM, Davis M. Mechanisms of fear extinction. Molecular Psychiatry. 12: 120-50. PMID 17160066 DOI: 10.1038/sj.mp.4001939 |
0.474 |
|
2006 |
Norrholm SD, Jovanovic T, Vervliet B, Myers KM, Davis M, Rothbaum BO, Duncan EJ. Conditioned fear extinction and reinstatement in a human fear-potentiated startle paradigm. Learning & Memory (Cold Spring Harbor, N.Y.). 13: 681-5. PMID 17142300 DOI: 10.1101/Lm.393906 |
0.463 |
|
2006 |
Jovanovic T, Norrholm SD, Keyes M, Fiallos A, Jovanovic S, Myers KM, Davis M, Duncan EJ. Contingency awareness and fear inhibition in a human fear-potentiated startle paradigm. Behavioral Neuroscience. 120: 995-1004. PMID 17014251 DOI: 10.1037/0735-7044.120.5.995 |
0.46 |
|
2006 |
Toufexis DJ, Myers KM, Davis M. The effect of gonadal hormones and gender on anxiety and emotional learning. Hormones and Behavior. 50: 539-49. PMID 16904674 DOI: 10.1016/j.yhbeh.2006.06.020 |
0.343 |
|
2006 |
Myers KM, Ressler KJ, Davis M. Different mechanisms of fear extinction dependent on length of time since fear acquisition. Learning & Memory (Cold Spring Harbor, N.Y.). 13: 216-23. PMID 16585797 DOI: 10.1101/lm.119806 |
0.488 |
|
2006 |
Davis M, Myers KM, Chhatwal J, Ressler KJ. Pharmacological treatments that facilitate extinction of fear: relevance to psychotherapy. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 3: 82-96. PMID 16490415 DOI: 10.1016/J.Nurx.2005.12.008 |
0.519 |
|
2005 |
Jovanovic T, Keyes M, Fiallos A, Myers KM, Davis M, Duncan EJ. Fear potentiation and fear inhibition in a human fear-potentiated startle paradigm. Biological Psychiatry. 57: 1559-64. PMID 15953493 DOI: 10.1016/J.Biopsych.2005.02.025 |
0.483 |
|
2005 |
Chhatwal JP, Myers KM, Ressler KJ, Davis M. Regulation of gephyrin and GABAA receptor binding within the amygdala after fear acquisition and extinction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 502-6. PMID 15647495 DOI: 10.1523/Jneurosci.3301-04.2005 |
0.406 |
|
2005 |
Davis M, Myers KM, Ressler KJ, Rothbaum BO. Facilitation of extinction of conditioned fear by D-cycloserine: Implications for psychotherapy Current Directions in Psychological Science. 14: 214-219. DOI: 10.1111/j.0963-7214.2005.00367.x |
0.44 |
|
2004 |
Myers KM, Davis M. AX+, BX- discrimination learning in the fear-potentiated startle paradigm: possible relevance to inhibitory fear learning in extinction. Learning & Memory (Cold Spring Harbor, N.Y.). 11: 464-75. PMID 15254216 DOI: 10.1101/lm.74704 |
0.462 |
|
2004 |
Myers K, Goulet M, Rusche J, Boismenu R, Davis M. Inhibition of fear potentiated startle in rats following peripheral administration of secretin. Psychopharmacology. 172: 94-9. PMID 14586542 DOI: 10.1007/S00213-003-1633-5 |
0.425 |
|
2003 |
Davis M, Walker DL, Myers KM. Role of the amygdala in fear extinction measured with potentiated startle. Annals of the New York Academy of Sciences. 985: 218-32. PMID 12724161 DOI: 10.1111/J.1749-6632.2003.Tb07084.X |
0.507 |
|
2002 |
Myers KM, Davis M. Behavioral and neural analysis of extinction. Neuron. 36: 567-84. PMID 12441048 DOI: 10.1016/S0896-6273(02)01064-4 |
0.451 |
|
2002 |
Davis M, Myers KM. The role of glutamate and gamma-aminobutyric acid in fear extinction: clinical implications for exposure therapy. Biological Psychiatry. 52: 998-1007. PMID 12437940 DOI: 10.1016/S0006-3223(02)01507-X |
0.481 |
|
Show low-probability matches. |